CLINICAL TRIALS PROFILE FOR ZONISAMIDE
✉ Email this page to a colleague
All Clinical Trials for zonisamide
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00047567 ↗ | Open-label Adjunctive Zonisamide for Bipolar Disorder | Terminated | Elan Pharmaceuticals | Phase 4 | 2002-07-01 | To study the safety and efficacy of zonisamide as adjunctive therapy for children and adolescents with bipolar I or II disorder. |
NCT00055484 ↗ | A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache | Completed | Elan Pharmaceuticals | Phase 2 | 2002-03-01 | The purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache. |
NCT00056576 ↗ | Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy | Completed | Eisai Inc. | Phase 3 | 2002-02-01 | The purpose of this study is to determine whether zonisamide alone is effective as a treatment for epilepsy in newly diagnosed cases. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for zonisamide
Condition Name
Clinical Trial Locations for zonisamide
Trials by Country
Clinical Trial Progress for zonisamide
Clinical Trial Phase
Clinical Trial Sponsors for zonisamide
Sponsor Name